Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP671664.RAR4mqGLud6QNrveEEguVxUUo57R6EeBr6l75Y0Z8F-MU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP671664.RAR4mqGLud6QNrveEEguVxUUo57R6EeBr6l75Y0Z8F-MU130_assertion type Assertion NP671664.RAR4mqGLud6QNrveEEguVxUUo57R6EeBr6l75Y0Z8F-MU130_head.
- NP671664.RAR4mqGLud6QNrveEEguVxUUo57R6EeBr6l75Y0Z8F-MU130_assertion description "[Patients with high-risk human leukocyte antigen (HLA)-DR-DQ genotypes for type 1 diabetes (T1D) were compared with HLA-matched controls to evaluate T1D risk for other HLA loci, including HLA-A, -B, -Cw, and DPB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671664.RAR4mqGLud6QNrveEEguVxUUo57R6EeBr6l75Y0Z8F-MU130_provenance.
- NP671664.RAR4mqGLud6QNrveEEguVxUUo57R6EeBr6l75Y0Z8F-MU130_assertion evidence source_evidence_literature NP671664.RAR4mqGLud6QNrveEEguVxUUo57R6EeBr6l75Y0Z8F-MU130_provenance.
- NP671664.RAR4mqGLud6QNrveEEguVxUUo57R6EeBr6l75Y0Z8F-MU130_assertion SIO_000772 18486765 NP671664.RAR4mqGLud6QNrveEEguVxUUo57R6EeBr6l75Y0Z8F-MU130_provenance.
- NP671664.RAR4mqGLud6QNrveEEguVxUUo57R6EeBr6l75Y0Z8F-MU130_assertion wasDerivedFrom befree-2016 NP671664.RAR4mqGLud6QNrveEEguVxUUo57R6EeBr6l75Y0Z8F-MU130_provenance.
- NP671664.RAR4mqGLud6QNrveEEguVxUUo57R6EeBr6l75Y0Z8F-MU130_assertion wasGeneratedBy ECO_0000203 NP671664.RAR4mqGLud6QNrveEEguVxUUo57R6EeBr6l75Y0Z8F-MU130_provenance.